 - Participant must be on a stable 3 drug regimen of Highly Active Antiretroviral Therapy for at least 4 weeks prior to screening and having a CD4 positive cell count of 350 cellsmicroliter. Also participant must be in an otherwise reasonable good medical condition Additional Inclusion Criteria Children Participants 